Pharmaceutical

STAT+: From ‘Jeopardy!’ to Politico, the PBM ad wars ar...

While watching “Jeopardy!”, “every single commercial break practically, I feel l...

STAT+: What to know about this summer’s landmark Wegovy...

Novo Nordisk will soon release results from a study that, if successful, could f...

STAT+: UPenn and St. Luke’s have withdrawn from US News...

“Shouldn’t we be focusing on doing what’s right for our community, not what’s ri...

Opinion: Biden promised a ‘war on cancer’ — but declare...

Ending cancer is an achievable goal, but new Biden administration policies are s...

STAT+: With savvy bets, a dynamic duo makes Eli Lilly o...

With weight loss and Alzheimer’s data, a dynamic duo powers Eli Lilly to new hei...

Black Americans living in disadvantaged neighborhoods a...

The new study “addresses some of the environmental pressures that contribute to ...

STAT+: NIH halts funding for Colombian research facilit...

The NIH has halted funding for a pair of malaria research facilities in Colombia...

First pediatric study to test neutralizing antibodies a...

When children living with HIV are injected with neutralizing antibodies, the tre...

STAT+: Pharmalittle: Novo Nordisk spent $11 million on ...

Novo Nordisk paid for meals and travel for thousands of doctors to promote Ozemp...

The 27 best books and podcasts on health and science to...

Check out the annual STAT summer book/podcast list, with recommendations from @n...

Does the hype around generative AI reflect its technolo...

ChatGPT's release to the public in November 2022 started a wave of global intere...

Incyte’s non-segmental vitiligo treatment approved in UK

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelur...

MHRA reveals new corporate plan to expedite drug regula...

The corporate strategy aims to introduce new legislation for faster regulations,...

EC approves Vertex’s Orkambi for cystic fibrosis in chi...

The EC approved extending the label for Vertex Pharmaceuticals’ Orkambi to treat...

FSD Pharma names Zeeshan Saeed as new CEO

FSD Pharma has named Zeeshan Saeed as the new chief executive officer (CEO) of t...

OSE Immunotherapeutics’ Tedopi gains US patent for canc...

The United States Patent and Trademark Office has provided a new patent for OSE ...